Get the Stockscreener App
27.73
0.84%
-0.19
Enovis Corp stock is traded at $27.73, with a volume of 639.61K.
It is down -0.84% in the last 24 hours and up +2.47% over the past month.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
See More
Previous Close:
$27.92
Open:
$27.99
24h Volume:
639.61K
Relative Volume:
0.80
Market Cap:
$1.59B
Revenue:
$2.19B
Net Income/Loss:
$-829.17M
P/E Ratio:
-1.946
EPS:
-14.25
Net Cash Flow:
$-3.95M
1W Performance:
+3.93%
1M Performance:
+2.47%
6M Performance:
-16.15%
1Y Performance:
-38.14%
1-Day Range:
$27.41
$28.11
1-Week Range:
$26.24
$28.11
52-Week Range:
$25.46
$49.38
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
27.74 | 1.60B | 2.19B | -829.17M | -3.95M | -14.25 |
|
ABT
Abbott Laboratories
|
127.03 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.64 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.64 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.78 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.58 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Weakness - Yahoo Finance
A Look At Enovis (ENOV) Valuation After Creating A New Chief Administrative Officer Role - simplywall.st
BTIG Initiates Enovis Corp(ENOV.US) With Buy Rating, Announces Target Price $41 - 富途牛牛
BTIG Initiates Enovis at Buy With $41 Price Target - marketscreener.com
BTIG initiates Enovis stock with Buy rating, cites growth potential By Investing.com - Investing.com Nigeria
This Spire Global Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Benzinga
ENOV: BTIG Initiates Coverage with a "Buy" Rating and $41 PT | E - GuruFocus
BTIG Initiates Coverage of Enovis (ENOV) with Buy Recommendation - Nasdaq
Enovis names Oliver Engert as CAO - Medical Buyer
Enovis Appoints Oliver Engert as Chief Administrative Officer - BioSpace
Enovis appoints McKinsey veteran Oliver Engert as chief administrative officer By Investing.com - Investing.com Australia
Enovis appoints McKinsey veteran Oliver Engert as chief administrative officer - Investing.com
UBS lowers Enovis stock price target to $50 on updated estimates - Investing.com Canada
Enovis Corporation (NYSE:ENOV) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Allspring Global Investments Holdings LLC Trims Stock Position in Enovis Corporation $ENOV - MarketBeat
Enovis Insiders Placed Bullish Bets Worth US$738.6k - 富途牛牛
Enovis Corporation Announces Participation in Upcoming Investor Conferences - MSN
EBIT per share of Enovis Corporation – LSE:0I1B - TradingView — Track All Markets
Enovis Corporation Reports Strong Growth Amid Challenges - MSN
Enovis Corporation Common Stock (NY: ENOV - FinancialContent
Osaic Holdings Inc. Acquires 50,156 Shares of Enovis Corporation $ENOV - MarketBeat
Wedge Capital Management L L P NC Sells 111,993 Shares of Enovis Corporation $ENOV - MarketBeat
Assenagon Asset Management S.A. Buys Shares of 133,319 Enovis Corporation $ENOV - MarketBeat
Canaccord Genuity slashes PT on Enovis Corporation (ENOV) to $50 from $58 - MSN
Canaccord Genuity Slashes PT on Enovis Corporation (ENOV) to $50 From $58 - Yahoo Finance
Thrivent Financial for Lutherans Sells 93,804 Shares of Enovis Corporation $ENOV - MarketBeat
Volatility Watch: Why Enovis Corporation stock is trending among retail tradersJuly 2025 Sector Moves & Fast Gaining Stock Reports - Улправда
Will Enovis Corporation stock benefit from green energy trendsJuly 2025 Action & Accurate Buy Signal Alerts - Улправда
How buybacks impact Enovis Corporation stock valueJuly 2025 Review & Real-Time Stock Movement Alerts - Улправда
Sell Signal: Why Enovis Corporation stock is a value investor pick2025 Trade Ideas & Free Expert Verified Stock Movement Alerts - Улправда
Aug Retail: How risky is Enovis Corporation stock compared to peersGap Down & Low Drawdown Trading Strategies - Улправда
Freedom Capital Markets Initiates Enovis Corp(ENOV.US) With Buy Rating, Announces Target Price $45 - 富途牛牛
Enovis (FRA:C520) EV-to-OCF : 13.01 (As of Dec. 19, 2025) - GuruFocus
Why Enovis Corporation stock is in analyst buy zone2025 Institutional Moves & High Accuracy Trade Alerts - DonanımHaber
Enovis (NYSE:ENOV) Price Target Lowered to $50.00 at Canaccord Genuity Group - MarketBeat
Can Enovis Corporation (C520) stock sustain double digit ROEPortfolio Gains Report & Safe Investment Capital Preservation Plans - Улправда
Will Enovis Corporation stock recover faster than peersJuly 2025 Analyst Calls & Risk Controlled Stock Alerts - DonanımHaber
Enovis initiated with a buy at Freedom Capital - MSN
How risky is Enovis Corporation stock compared to peersPortfolio Gains Summary & Risk Controlled Swing Alerts - Улправда
Why Enovis Corporation stock is a value investor pick2025 Volume Leaders & Safe Capital Growth Tips - Улправда
Sports Doc Talk Podcast: Michael McBrayer on the Future of Sports Medicine - marketscreener.com
Enovis (ENOV) Gets a Buy from Canaccord Genuity - The Globe and Mail
Is Enovis’ Extended Debt Maturities And HR Succession Plan Altering The Investment Case For ENOV? - simplywall.st
ENOV (Enovis) EV-to-OCF : 13.35 (As of Dec. 18, 2025) - GuruFocus
Why Enovis (ENOV) Stock Is Trading Up Today - The Globe and Mail
Canaccord Genuity Maintains Enovis (ENOV) Buy Recommendation - Nasdaq
Enovis (ENOV) Initiated with a Buy at Freedom Capital Markets - The Globe and Mail
Enovis (ENOV) Target Price Lowered by Canaccord Genuity | ENOV S - GuruFocus
Enovis (NYSE:ENOV) Trading 5.8% HigherWhat's Next? - MarketBeat
Freedom Capital Markets Initiates Coverage of Enovis (ENOV) with Buy Recommendation - Nasdaq
Enovis stock initiated with Buy rating at Freedom Capital Markets By Investing.com - Investing.com Canada
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):